Presentation Information

[3CTBP-03]Strategy for the Industrialization of MSC-based Private-pay Care: Establishing Superiority of Autologous Cells through Standardized Manufacturing

○Keita Inoue1 (1. CPC Corporation (Japan))

Keywords:

mesenchymal stem cells,cell therapy

Password required to view

Password required to view

Comment

To browse or post comments, you must log in.Log in